Both FMR4 and FMR6 are thought to regulate FMR1 stability, splicing, subcellular localization and translational efficiency in FXTAS, and have been proposed to be useful biomarkers allowing for early detection and therapeutic intervention in fragile X syndrome and FXTAS. The gene discussed is FMR1; the disease is fragile X syndrome.